Get started
Author

Shogo Amano

Observed names: Amano, Shogo, S., Amano, SHOGO AMANO, Shogo AMANO
ORCID: 0000-0002-4487-2420
Observed ORCID: 0000-0002-4487-2420
OpenAlex ID: A5084841968
Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growthin vitroandin vivo
2018 · Shuhei Shinoda, Seiji Kaino, et al. · Oncotarget · 37
PDF
RETRACTED ARTICLE: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
2020 · Shogo Amano, Seiji Kaino, et al. · BMC Cancer · 26
PDF
CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer
2022 · Yutaka Suehiro, Shigeyuki Suenaga, et al. · Oncology · 8
EUS-guided antegrade metallic stent placement using the stent-in-stent method with a 6-Fr novel slim delivery system in a patient with malignant hilar biliary obstruction
2021 · Shigeyuki Suenaga, Seiji Kaino, et al. · Endoscopic Ultrasound · 7
PDF
Heat Shock Protein 27 Expression in EUS-FNA Samples Can Predict Gemcitabine Sensitivity in Pancreatic Cancer
2018 · MICHITAKA KAWANO, SEIJI KAINO, et al. · In Vivo · 5
PDF
A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia
2023 · Shogo Amano, Shigeyuki Suenaga, et al. · DEN Open · 3
PDF
Comparison of Duodenal Stenting and Gastrojejunostomy for Duodenal Obstruction with Biliary Obstruction
2022 · Hirofumi Harima, Seiji Kaino, et al. · Journal of Gastrointestinal Surgery · 2
Bile leakage from a proximal aperture of the dedicated plastic stent: a technical pitfall during endoscopic ultrasound-guided hepaticogastrostomy
2020 · Hirofumi Harima, Seiji Kaino, et al. · BMJ Case Reports · 2
PDF
EUS-guided antegrade stenting using a braided metal stent with a 6-Fr novel slim delivery system for malignant biliary stricture following Roux-en-Y reconstruction (with video)
2020 · Hirofumi Harima, Seiji Kaino, et al. · Endoscopic Ultrasound · 2
PDF
Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
2023 · Shogo Amano, Seiji Kaino, et al. · BMC Cancer · 1
PDF
Lumen-apposing metal stent for peripancreatic fluid collection contributes to early improvement of nutritional status: A multicenter retrospective study (YCR-P001)
2026 · Takanori Tsuyama, Shigeyuki Suenaga, et al. · Medicine
[A Case of Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm( MiNEN) in the Pancreatic Body Associated with Primary Renal Lymphoma].
2025 · Yukari Hamanaga, Satoshi Matsukuma, et al. · PubMed
[Our Experience of Staging Laparoscopy for Patients with Pancreatic Cancer before Initial Treatment].
2024 · Masaki Iwado, Satoshi Matsukuma, et al. · PubMed
Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
2023 · Shogo Amano, Seiji Kaino, et al. · BMC Cancer
A case of MEN1 presenting with multiple pancreatic neuroendocrine tumors with large cyst-like morphology difficult to differentiate from mucinous cystic neoplasm (MCN)
2023 · Yasuharu OHTA, Masaru AKIYAMA, et al. · Suizo
PDF
Supplementary Material for: CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer
2022 · Y., Suehiro, S., Suenaga, et al. · Figshare
Efficacy of quantitative analysis for differentiating pancreatic solid lesions using contrast-enhanced endoscopic ultrasonography
2021 · Yasuda, Mayumi, Kaino, Seiji, et al. · Institutional Repositories DataBase (IRDB)
PDF
Endoscopic ultrasound-guided antegrade stenting through a hilar cholangiocarcinoma associated with a severe biliary infection
2020 · Hirofumi Harima, Seiji Kaino, et al. · Endoscopy
PDF
Deferasirox (DFX), A Newly Oral Iron Chelator, with Gemcitabine (GEM) Inhibited Pancreatic Cancer Cell Proliferation and Induced Apoptosis in vitro and in vivo
2017 · Shuhei Shinoda, Seiji Kaino, et al. · Gastroenterology
Works count: 19
Citation count: 91
H-index: 5
I10-index: 2
Year
Topic
Type